Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA study
Geert D’Haens(Amsterdam University Medical Centers), W. Sandborn, Maria Kłopocka(Nicolaus Copernicus University), Jules J. Claus, S. Lee, Dino Tarabar(Military Medical Academy), Fabio Cataldi(Pfizer (United States)), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), L. M. Brown, Xavier Hébuterne(Université Côte d'Azur), Ken Gorelick(Pfizer (United States)), Ansuman Banerjee, D. I. Park, E Louis, Walter Reinisch(Medical University of Vienna), M. Hassan-Zahraee, A. Ahmad, John Cheng(Pfizer (United States))
Unknown
January 1, 2015
Cited by 16
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865